NM_000398.7:c.806C>T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PM1PM2PP5BP4
The NM_000398.7(CYB5R3):c.806C>T(p.Pro269Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000871 in 1,608,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000398.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYB5R3 | ENST00000352397.10 | c.806C>T | p.Pro269Leu | missense_variant | Exon 9 of 9 | 1 | NM_000398.7 | ENSP00000338461.6 | ||
ENSG00000289517 | ENST00000617178.5 | n.341C>T | non_coding_transcript_exon_variant | Exon 4 of 14 | 1 | ENSP00000482500.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000168 AC: 4AN: 238260Hom.: 0 AF XY: 0.0000233 AC XY: 3AN XY: 129024
GnomAD4 exome AF: 0.00000824 AC: 12AN: 1456032Hom.: 0 Cov.: 32 AF XY: 0.00000691 AC XY: 5AN XY: 723740
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74334
ClinVar
Submissions by phenotype
Deficiency of cytochrome-b5 reductase Pathogenic:1
The CYB5R3 c.806C>T (p.Pro269Leu) variant is a missense variant that has been reported in two studies, in which it is found in a total of 59 individuals with congenital methemoglobinemia type I, including at least in 16 in a homozygous state (Puzyrev and Maximova 2008; Burtseva et al. 2017). The p.Pro269Leu is a founder variant in the Yakut population with a frequency of heterozygous carriers of about 1% in the entire population of the Republic of Sakha and 7% in the indigenous Yakut population (Galeeva et al. 2013; Burtseva et al. 2017). Control data are unavailable for this variant, which is reported at a frequency of 0.000119 in the Latino population of the Genome Aggregation Database. Based on the collective evidence and application of the ACMG criteria, the p.Pro269Leu variant is classified as likely pathogenic for congenital methemoglobinemia. -
not provided Uncertain:1
This variant is present in population databases (rs754251915, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CYB5R3-related conditions. ClinVar contains an entry for this variant (Variation ID: 989273). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 269 of the CYB5R3 protein (p.Pro269Leu). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at